SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-021228
Filing Date
2023-05-11
Accepted
2023-05-11 16:09:18
Documents
14
Period of Report
2023-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dice-20230511.htm   iXBRL 8-K 57234
2 EX-99.1 dice-ex99_1.htm EX-99.1 108954
3 GRAPHIC img234593118_0.jpg GRAPHIC 14750
  Complete submission text file 0000950170-23-021228.txt   317362

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dice-20230511_lab.xml EX-101.LAB 14018
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dice-20230511.xsd EX-101.SCH 2493
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dice-20230511_pre.xml EX-101.PRE 10303
8 EXTRACTED XBRL INSTANCE DOCUMENT dice-20230511_htm.xml XML 4942
Mailing Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filer) CIK: 0001645569 (see all company filings)

IRS No.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40794 | Film No.: 23911049
SIC: 2834 Pharmaceutical Preparations